All In Biotech

Free tool

FAERS Monitor: Vpriv

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 022575 or its brand name (Vpriv, Velaglucerase Alfa). Reports on generic versions are filed under their own applications.

Reports

2,052

Serious

1,718

84% of reports

Hospitalization

880

Death reported

280

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • inappropriate schedule of product administration212
  • product dose omission issue198
  • covid-19167
  • fatigue154
  • death127
  • pyrexia114
  • fall112
  • malaise111
  • weight increased106
  • headache105
  • infusion related reaction102
  • nausea98
  • arthralgia95
  • abdominal pain93
  • weight decreased91

Reports by year received

View as table
YearReports
201012
201121
201243
201374
2014114
2015101
201697
201784
2018141
2019158
2020160
2021313
2022224
2023154
2024173
2025112
202671

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,107 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion related reactionSignal10215.813.11,401
inappropriate schedule of product administrationSignal21212.110.62,157
covid-19Signal1679.88.41,315
product dose omission issueSignal1986.96.01,007
weight increasedSignal1064.94.0324
abdominal painSignal934.13.4217
fallSignal1123.52.9195
pyrexiaSignal1143.42.8192
weight decreasedSignal913.32.7149
malaiseSignal1112.62.2109
arthralgiaSignal952.31.973
fatigueSignal1542.01.782
headache1051.71.432
death1271.51.322
nausea981.31.06

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.